APA (7th ed.) Citation

K, M., Y, Y., T, S., T, K., A, M., K, K., . . . A, K. (2026). Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 244, 116902. https://doi.org/10.1016/j.ejca.2026.116902

Chicago Style (17th ed.) Citation

K, Matsumoto, et al. "Impact of Preexisting Interstitial Lung Disease on Pneumonitis and Survival During First-line Immune Checkpoint Inhibitor-based Therapy in Non-small Cell Lung Cancer." European Journal of Cancer (Oxford, England : 1990) 244 (2026): 116902. https://doi.org/10.1016/j.ejca.2026.116902.

MLA (9th ed.) Citation

K, Matsumoto, et al. "Impact of Preexisting Interstitial Lung Disease on Pneumonitis and Survival During First-line Immune Checkpoint Inhibitor-based Therapy in Non-small Cell Lung Cancer." European Journal of Cancer (Oxford, England : 1990), vol. 244, 2026, p. 116902, https://doi.org/10.1016/j.ejca.2026.116902.